• 5300 Citations
  • 33 h-Index
1988 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2001

Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase

Vonderheide, R. H., Anderson, K. S., Hahn, W. C., Butler, M. O., Schultze, J. L. & Nadler, L. M., Jan 1 2001, In : Clinical Cancer Research. 7, 11, p. 3343-3348 6 p.

Research output: Contribution to journalArticle

95 Scopus citations

Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals

Vonderheide, R. H., Schultze, J. L., Anderson, K. S., Maecker, B., Butler, M. O., Xia, Z., Von Bergwelt-Baildon, M. S., Bedor, M. M., Hoar, K. M., Schnipper, D. R., Stephans, K. F., Hahn, W. C., Nadler, L. M., Wucherpfennig, K. W., Kuroda, M. J., Letvin, N. L. & Brooks, M. W., Dec 1 2001, In : Cancer Research. 61, 23, p. 8366-8370 5 p.

Research output: Contribution to journalArticle

75 Scopus citations

Linking genomics to immunotherapy by reverse immunology mmmunomics' in the New Millennium

Maecker, B., Von Bergwelt-Baildon, M. S., Anderson, K. S., Vonderheide, R. H. & Schultze, J. L., Jan 1 2001, In : Current Molecular Medicine. 1, 5, p. 609-619 11 p.

Research output: Contribution to journalArticle

27 Scopus citations

Tumour immunotherapy: New tools, new treatment modalities and new T-cell antigens

Schultze, J. L., Maecker, B., Von Bergwelt-Baildon, M. S., Anderson, K. S. & Vonderheide, R. H., Feb 1 2001, In : Vox Sanguinis. 80, 2, p. 81-89 9 p.

Research output: Contribution to journalReview article

21 Scopus citations
2000

Potential of antigen-specific adoptive immunotherapy using peptide/mhc tetramers and microbeads for highyield purification of cytotoxic t lymphocytes from peripheral blood

Andersen, K. S., Wucherpfennig, K. A., Nicholas Haining, W., Schultze, J. L., Maecker, B., Xia, Z., Butler, M. O., Vonderheide, R. H. & Nadler, L. M., Dec 1 2000, In : Blood. 96, 11 PART I, p. 177a

Research output: Contribution to journalArticle

1994

A role for calnexin (IP90) in the assembly of class II MHC molecules

Anderson, K. S. & Cresswell, P., Feb 1 1994, In : EMBO Journal. 13, 3, p. 675-682 8 p.

Research output: Contribution to journalArticle

103 Scopus citations
1993
Open Access
220 Scopus citations

Intracellular transport of class I MHC molecules in antigen processing mutant cell lines

Anderson, K. S., Alexander, J., Wei, M. & Cresswell, P., Jan 1 1993, In : Journal of Immunology. 151, 7, p. 3407-3419 13 p.

Research output: Contribution to journalArticle

100 Scopus citations
1992

Transport and expression of class I MHC glycoproteins in an antigen- processing mutant cell line

Click, E. M., Anderson, K. S., Androlewicz, M. J., Wei, M. L. & Cresswell, P., Dec 1 1992, In : Cold Spring Harbor symposia on quantitative biology. 57, p. 571-578 8 p.

Research output: Contribution to journalArticle

7 Scopus citations
1991

Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class i-restricted cell-mediated lysis

Anderson, K., Cresswell, P., Gammon, M., Hermes, J., Williamson, A. & Zweerink, H., Aug 1 1991, In : Journal of Experimental Medicine. 174, 2, p. 489-492 4 p.

Research output: Contribution to journalArticle

Open Access
195 Scopus citations
1988

Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole

Pearson, W. R., Reinhart, J., Sisk, S. C., Anderson, K. S. & Adler, P. N., Jan 1 1988, In : Journal of Biological Chemistry. 263, 26, p. 13324-13332 9 p.

Research output: Contribution to journalArticle

74 Scopus citations